Closed mbhall88 closed 1 year ago
Basically gene deletion detection would be a huge win . Literature reports are limited but partially because people don't look. Florencia in our group is now looking for them in cryptic. But I would expect gene deletions to cause resistance for all 4 genes where we say any frame shift causes resistance. Also, would be great to detect it for mmpR5 and MmpL5 and mmpS5.
Mykrobe can do it (it does do it for staph) and is essentially an error of judgement on my part that it doesn't for TB (Basically always something urgent pushes doing it down the priority list)
Arnold also has a case of a pncA deletion.
I can easily look through our samplesheet of 44K samples for these gene deletions. Only thing is, if we add it, I would also need to add it for mykrobe I guess. I would just need Martin to clarify how I link gene absence probes to a drug.
Yeah I guess so. Martin on vacation from Thursday fyi
So had a look to see if there's any gene deletions in the ~8500, not expecting too many given the scarcity in the literature
rpoB 1
ahpC 2
embA 2
embB 2
fabG1 2
gid 2
gyrA 2
inhA 2
rplC 2
eis 3
ethA 14
katG 15
rrs 27
pncA 31
Wowza. This shows the number of samples a gene deletion was detected in.
I had a quick look at some of the katG ones and all of those are FN INH for all callers. So adding gene deletion detection is going to boost our sensitivity nicely (at least for INH)!
NICE
Re rareness in the literature, I really think it is under measured. This is why we're finally doing it on the cryptic data
Okay, so we detect gene deletions in the four genes where any nonsense mutation (or frameshift) cause resistance: pncA, katG, ethA, gid. The diff between before/after this feature is
Tool | Drug | ΔFN | ΔFP |
---|---|---|---|
drprg | Amikacin | 0 | 0 |
drprg | Capreomycin | 0 | 0 |
drprg | Delamanid | 0 | 0 |
drprg | Ethambutol | 0 | 0 |
drprg | Ethionamide | -4 | 0 |
drprg | Isoniazid | -10 | 0 |
drprg | Kanamycin | 0 | 0 |
drprg | Levofloxacin | 0 | 0 |
drprg | Linezolid | 0 | 0 |
drprg | Moxifloxacin | 0 | 0 |
drprg | Ofloxacin | 0 | 0 |
drprg | Pyrazinamide | -1 | 3 |
drprg | Rifampicin | 0 | 0 |
drprg | Streptomycin | 0 | 0 |
I'll describe the three FPs
These do look weird. Is ERR046857 even wgs?
These do look weird. Is ERR046857 even wgs?
From what I can tell. It is also from 2011 though....
Arnold provided me with a MTB sample that has a 32kbp deletion which include katG. This seems to be quite rare in clinical samples? I see https://doi.org/10.1016/j.ijmm.2021.151506 (2021) claims to be the first report of this...
When I run drprg on this sample, we produce an S call for INH, but katG indeed is missing from the VCF - i.e. pandora has noted it's absence. Both mykrobe and tb-profiler call S too. I think mykrobe's panel can be altered to detect gene absence from looking at the wiki, but I'm not clear on how you link this to a drug...
So, this means we should be able to quite easily detect gene deletions. The next question becomes should we do about this. I did a literature search for gene deletions of some other resistance-associated genes but I'm struggling to find any papers that have assessed gene deletion impact on resistance, except for katG/INH. Based on the intro to that paper above maybe people assume the fitness cost is too high for the bug to survive?
A last question is whether this goes in the paper with some case studie(s) of samples with gene deletions?